Ambee Partners With Digital Health Company VitalFlo To Provide Air Quality Data And Respiratory Health Monitoring Solution

Through Ambee’s data, clinicians can forecast potential environmental triggers and adjust patient action plans accordingly.

Ambee, a global platform for hyperlocal environmental data, has partnered with US-based digital health company VitalFlo, to provide air quality data and respiratory health monitoring solutions.

VitalFlo is a digital health company that helps clinical teams measure and monitor the respiratory health of their patients. Using environmental data collected by Ambee, VitalFlo enables clinical teams to provide proactive and responsive management of respiratory diseases and conditions. Through advanced trends, patient status alerts, and detailed analytics, clinicians can forecast potential environmental triggers and adjust patient action plans accordingly, improving the quality of life for all those afflicted.

Air pollution continues to be a major public health concern around the world. According to a report by the American Thoracic Society, children and adults with lung disorders such as asthma and chronic obstructive pulmonary disease (COPD), newborn infants, and the elderly are at a higher risk of developing health problems due to outdoor air pollution. Higher levels of air pollution are linked to decreased lung function, asthma attacks, COPD exacerbations, and much more. The first step towards mitigating the impact of air pollution is being aware of the air we breathe. Ambee’s air quality data helps visualize and quantify ambient air pollution at any given location, down to the postcode and neighborhood level.

Commenting on the partnership, Jaideep Singh Bachher, CEO, Ambee, said, “VitalFlo and Ambee have a shared vision to improve the lives of people that are affected by climate change and poor air quality. We are excited to partner with a brand so deeply involved in improving the experience of those living with chronic respiratory disease. With Ambee’s data, clinicians can better identify environmental triggers and create personalized patient treatment plans.”

“As a company focused on respiratory health, it’s crucial for us to be monitoring the ways that air quality can impact the health outcomes of our asthma and COPD patients,” added Luke Marshall, CEO, and Founder, VitalFlo. “Ambee provides great access to high quality and highly localized data to help us monitor things like pollen, particulate, and ozone which can trigger acute respiratory health events.”

Ambee is an environmental and climate intelligence company that builds hyperlocal datasets for air quality, pollen, weather, active fires, and other climate parameters. The company was founded with a mission to democratize access to environmental data and tools that enable a better and healthier living experience. Ambee’s environmental APIs aggregate raw data from multiple sources, such as on-ground sensors, satellite imagery, and open-source traffic data, and process it with proprietary AI algorithms to build reliable and accurate datasets.

Ambee provides location-specific and real-time data that can be used by a wide range of markets that aim to build a healthier planet. Businesses and administrators across the globe integrate Ambee’s AI-powered, scientifically-validated data into their businesses and lives to create sustainable and climate-friendly surroundings.

To know more, visit Ambee.

About VitalFlo

VitalFlo is a digital health company launched in 2017 with offices in Raleigh, NC, and Portland, OR. It helps clinical teams across sectors measure the respiratory health of their patients. In a span of a few years, VitalFlo has proliferated by partnering with the nation’s leading respiratory research institutions, primary care providers, and integrated delivery networks. VitalFlo is the recipient of a National Science Foundation Phase I & II SBIR, the NC IDEA Seed Grant, and was selected to join Techstars Impact 2019.With a suite of tools for pulmonary function testing, VitalFlo helps doctors rapidly assess the respiratory health of their asthma patients — both in the clinic and at home — and to update patient care plans.

To know more, visit

Source link